INTRODUCTION {#S1}
============

Obesity is associated with impaired immune responses to viral and bacterial infections and an increase in the frequency of nosocomial infections compared with non-obese patients ([@R9]; [@R16]; [@R22]; [@R38]; [@R39]). Obese subjects also show a greater decline in influenza-specific antibody and CD8+ T cells after vaccination compared with non-obese subjects ([@R34]). These effects are replicated in mouse models of influenza infection, in which diet-induced obesity impairs memory T cell responses after vaccination and increases mortality following challenge infection ([@R17]; [@R36]). Obesity can alter other aspects of host responses to infection, such as prolonging inflammation and impairing wound repair following influenza infection ([@R26]) and worsening the progression of HCV-induced liver disease. Obesity-associated inflammation may contribute to co morbidities associated with obesity, including increased incidence of acute pancreatitis, cardiovascular disease, diabetes, and cancer, each of which has an underlying immune component. Because obesity is increasingly prevalent, it is important to understand how obesity affects host defenses against different infections.

Obesity involves an increase in the mass of white adipose tissue (WAT), a physiologically significant tissue that regulates metabolism and nutritional homeostasis ([@R31]). WAT consists of adipocytes, endothelial cells, fibro-blasts, and immune cells, which change in abundance and function during the course of obesity. Obesity-induced changes in WAT include alterations in adipokine production, increased expression of pro-inflammatory cytokines, and the accumulation of M1 macrophages. However, it is unclear how these changes within adipose tissue may alter systemic adaptive immune responses to infection.

To understand the impact of WAT and obesity on T cell-based defenses, we examined the effect of obesity on memory T cell number and function in mice given acute lymphocytic choriomeningitis virus (LCMV-Armstrong) infection, a natural pathogen of mice that induces well-defined inflammatory, T cell, and B cell responses. We show that LCMV replicates in the WAT, resulting in virus-specific T cells that infiltrate the tissue, eliminate the infection, and persist there as memory cells. Memory T cells in WAT express unique phenotypic markers compared with memory T cells in the spleen. Adipose tissue T cells represent a major fraction of virus-specific T cells in mice, a population that was increased numerically by diet-induced obesity. Upon re-challenge with a disseminating variant of LCMV, immune obese mice, but not immune lean mice, showed greatly increased mortality that was T cell dependent and associated with fat necrosis, systemic release of lipases, and pancreatitis. Our data reveal a subset of memory cells that are greatly increased by obesity and associated with pancreatitis during infection.

RESULTS {#S2}
=======

LCMV Replicates in WAT and Is Resolved by 2 Weeks {#S3}
-------------------------------------------------

As an initial approach to understanding the contribution of the adipose tissue to local and systemic immune defenses, the level of infection within the perigonadal WAT was quantified at multiple times after LCMV-Armstrong infection. At day 4, the adipose tissue was highly infected, although there was about 100-fold less virus per gram than in the spleen ([Figure 1A](#F1){ref-type="fig"}). The adipose tissue continued to have high amounts of infection (10^5^ plaque-forming units \[PFUs\]/g) at day 8, whereas the infection was reduced to the limits of detection in the spleen. LCMV was cleared in both tissues by day 12, and there was no recrudescence at later times ([Figure 1A](#F1){ref-type="fig"} and data not shown). The kinetics and magnitude of infection differed in the spleen and WAT, which may relate to the availability of permissive targets in each site or the speed with which T cells can reach the tissue.

Adipocytes have a unique appearance; they are typically large with a lipid droplet, minimal cytoplasm, and a nucleus that is often adjacent to the plasma membrane. Gentle, differential centrifugation was used to separate adipocytes from cells of the stromal vascular fraction (SVF), a cell population that includes leukocytes, mesodermal or mesenchymal stromal vascular cells, pre-adipocytes, adipose-derived stem cells, pericytes, endothelial cells, and fibroblasts ([Figure 1B](#F1){ref-type="fig"}). Although most virus was recovered in the stromal vascular fraction, adipocytes carried low levels of infectious virus, roughly one-tenth the amount present in the entire tissue. Thus, WAT and adipocytes themselves are associated with viral infection.

LCMV infection resulted in inflammation of the WAT ([Figure 1C](#F1){ref-type="fig"}, top). Areas of inflammation contained leukocytes, and the adipocytes within these foci were smaller in size than neighboring adipocytes, suggesting apoptosis ([@R5]). Immunofluorescence staining revealed an increased population of CD3+ cells in the adipose tissue at days 14 and 40 after LCMV ([Figure 1C](#F1){ref-type="fig"}, bottom). Compared with adipose from uninfected mice, there was a 10-fold increase in leukocytes recovered from the WAT at day 8 ([Figure 1D](#F1){ref-type="fig"}). Much of this increase was due to a 280-fold increase in CD8+ T cells, resulting in \~ 4 × 10^6^ CD8+ T cells in the perigonadal adipose tissue. There was also a significant 6.7-fold increase in CD4+ T cells, leading to \~ 2 × 10^5^ CD4+ T cells in the WAT at day 8. CD4+ T cells continued to increase to \>20-fold by day 12, resulting in a peak of \~ 10^6^ CD4+ T cells ([Figures 1D](#F1){ref-type="fig"} and [S1C)](#SD1){ref-type="supplementary-material"}. During the first 2 weeks following infection, the relative increase in T cell frequencies was far greater in the WAT than in the spleen ([Figures S1A](#SD1){ref-type="supplementary-material"}--[S1C](#SD1){ref-type="supplementary-material"}). This was especially apparent when analyzing activated CD8+CD44^hi^ and CD4+CD44^hi^ T cells at day 8 ([Figure S1D](#SD1){ref-type="supplementary-material"}), which are likely specific for various epitopes of LCMV ([@R21]). An inflated population of CD8+CD44^hi^ and CD4+CD44^hi^ cells remained in the WAT to day 70 ([Figure S1D](#SD1){ref-type="supplementary-material"}). Thus, infection in WAT is associated with an early accumulation of T cells, virus elimination, and then persistence of a pool of CD44^hi^ T cells.

A Distinct Pool of Virus-Specific T Cells Accumulates in WAT after Infection {#S4}
----------------------------------------------------------------------------

Virus-infected cells should be recognizable by CD8+ T cells because MHC-I is expressed on adipocytes and infiltrating leukocytes. MHC-II is expressed by infiltrating F4/80+ macrophages but can be induced on adipocytes ([@R7]; [@R15]), so virus-specific CD4+ T cells may recognize viral material presented by antigen-presenting cells or possibly infected adipocytes. Because the infection was controlled in the adipose tissue and there was histological and fluorescence-activated cell sorting (FACS)-based evidence of infiltrating T cells, we considered that virus-specific T cells entered the tissue and mediated immune control.

Virus-specific T cells in the adipose tissue and spleen were quantified by tetramers at different times after infection. There was a prominent increase in the frequency of tetramer+ T cells in the WAT after infection, with the highest percentages at 1--2 weeks post-infection ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). GP~33--41~-specific CD8+ T cells in the WAT peaked in abundance at day 8 and were roughly 30-fold less abundant than in the spleen ([Figure 2B](#F2){ref-type="fig"}). Major expansions were also seen for DbNP~396--404~-specific and DbGP~276--286~-specific CD8+ T cells after infection ([Figure S1E](#SD1){ref-type="supplementary-material"}). The I-A^b^GP~67--80~-specific CD4+ T cell response in the spleen peaked at day 8 ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}), whereas the CD4+ T cell response in the WAT peaked at day 13 and was roughly one-third that in the spleen at this time ([Figure 2B](#F2){ref-type="fig"}). Thus, during the first 2 weeks of infection, as many as 5 × 10^5^ D^b^GP~33~-specific CD8+ T cells and 1 × 10^5^ IA^b^GP~67~-specific CD4+ T cells were in the fat pads. For perspective, these cells represented roughly 10% of what was present in the spleens of the same mice. In summary, the WAT represents a major site of virus-specific T cells that is largely uncharacterized.

After the peak response, there was a proportional \~ 10-fold contraction in DbGP~33~+ CD8+ T cells in both tissues by day 24 that stabilized in the spleen but continued to decline in the WAT before reaching stability at day 70 at roughly 10^4^ cells ([Figures 2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}). Approximately 10^4^ DbNP~396--404~-specific and DbGP~276--286~-specific CD8+ T cells were also found in WAT at memory time points ([Figure S1E](#SD1){ref-type="supplementary-material"}). Similar to the CD8+ T cell response, IA^b^GP~67~-specific CD4+ T cells were relatively stable in the spleen from day 24 onward, whereas tetramer+ CD4+ T cells continued to decline in the WAT between days 24 and 70. Thus, the CD4+ T cell response in WAT shows a delayed expansion and appears less stable compared with the spleen. At day 70 and 90 post-infection, memory CD4+ T cells in adipose tissue were roughly 5% of the number found in the spleen ([Figure 2B](#F2){ref-type="fig"} and data not shown).

The capacity of memory T cells to respond to antigen was assessed by intracellular cytokine staining (ICCS) assay. There was a large increase in the percentage of CD8+ T cells that could make IFNg (or TNF or IL-2) in response to GP~33--41~, NP~396--404~,or GP~276--286~ peptides in the spleen and WAT ([Figures 2C](#F2){ref-type="fig"}--[2E](#F2){ref-type="fig"} and [S1F](#SD1){ref-type="supplementary-material"} and data not shown), and these cells underwent contraction and were maintained to days 30--70. The overall number of cytokine-expressing memory CD8+ T cells was smaller in WAT compared with spleen ([Figures 2C](#F2){ref-type="fig"}, [2D](#F2){ref-type="fig"}, and [S1F](#SD1){ref-type="supplementary-material"}). Memory GP~33~-specific CD8+ T cells in the spleen made \>2-fold more IFNg per cell than those in the WAT ([Figure S1G](#SD1){ref-type="supplementary-material"}), perhaps because adipose tissue CD8+ T cells express PD1 ([Figure S1H](#SD1){ref-type="supplementary-material"}) and may be inhibited. The frequency of memory CD4+ T cells that could make IFNg in response to GP~61--80~ was greater in the WAT than spleen ([Figure 2C](#F2){ref-type="fig"}), though the overall number of cytokine-expressing memory CD4+ cells was lower in the WAT compared with spleen ([Figures 2D](#F2){ref-type="fig"} and [S1F](#SD1){ref-type="supplementary-material"}). The amount of cytokine made per CD4+ T cell in each compartment was similar ([Figure S1G](#SD1){ref-type="supplementary-material"}). These data show that the memory T cells persisting in WAT are capable of making pro-inflamma-tory cytokines.

Nearly all T cells in the spleen and WATwere Ki67+at day 8, indicating that the cells were actively dividing in response to infection ([Figure S1I](#SD1){ref-type="supplementary-material"}). For virus-specific CD8+ T cells, cell division quickly subsided to background levels (\~10%) in both compartments by day 13, although a low level of staining (\<20%) could be observed for splenic GP~276~-specific CD8+ T cells at day 21. In contrast, 60% of CD4+ T cells continued to proliferate at day 13 before subsiding to levels near background by day 21. In contrast to GP~33~-specific CD8+ T cells, GP~61~-specific CD4+ T cells incorporated BrdU when mice were pulsed from day 13 to 20 or from day 21 to 28 ([Figure S1J](#SD1){ref-type="supplementary-material"}). Interestingly, CD4+ T cells in the WAT showed far more BrdU incorporation than those in the spleen, suggesting that the adipose tissue environment sustains the proliferation of subsets of antigen-specific T cells for 2--3 weeks after infection has resolved. The percentage of CD4+ T cells incorporating BrdU appeared to decline over time, suggesting that factors in adipose tissue that stimulate CD4+ T cell proliferation diminish through this period, and normal homeo-static mechanisms may be at play at later memory time points.

Memory T Cells Present in WAT Are Distinct from Lymphoid, Circulating, and Mucosal Subsets {#S5}
------------------------------------------------------------------------------------------

Subsets of tissue-resident memory T (Trm) cells can be found in lung, skin, or intestinal locations following vaccination or infection. Trm cells are distinct from T cells circulating within the vascular system and persist locally in specific tissue sites for long periods of time without re-circulating ([@R32]; [@R35]). To address whether virus-specific memory T cells in adipose tissue are contaminants from blood, we performed intravascular staining, in which fluorescent antibodies against CD4 or CD8 are injected intravenously moments before tissue harvest ([@R2]); this technique identifies vascular T cells, including those in capillaries, from tissue-embedded T cells. To facilitate this analysis, we adoptively transferred congenic virus-specific TCR-transgenic P14+ CD8+ T cells (specific for GP~33--41~) or SMARTA+ CD4+ T cells (specific for GP61--80) to separate mice, immunized with LCMV-Armstrong, and then performed the intravascular staining at day 38, a memory time point. Gating on donor cells (Ly5a+), we observed that the vast majority of memory T cells found in our WAT cell preparation were not contaminants from circulation but located within the parenchyma of the tissue ([Figures 3A](#F3){ref-type="fig"} and [3B](#F3){ref-type="fig"}). These data also show that TCR-transgenic T cells persist in WAT, similar to endogenous memory T cells.

Flow cytometry was used to quantify the surface expression of various activation and memory markers on the donor memory T cells, comparing those in WAT with those in the spleen of the same mice ([Figure 3C](#F3){ref-type="fig"}). Like splenic memory CD8+ T cells, CD8+ T cells in the WAT were CD44^hi^CD62L^lo^ but also showed evidence of activation. CD8+ P14 cells in the WAT tended to express more CD69 and Ly6C than splenic P14 cells but were KLRG1^lo^ and CD127^lo^ and showed limited expression of CD103, unlike resident T cells in the lung, skin, or intestines. Adipose tissue memory CD8+ T cells expressed higher amounts of CD122, suggesting that the cells may favor IL-15 for homeo-static maintenance. Memory SMARTA CD4+ T cells in WAT were CD44^hi^CD62L^lo^CD69^lo^CD103^lo^, similar to their splenic counterparts. However, CD4+ T cells in adipose tissue expressed far higher levels of Ly6C and CD11a, suggesting recent activation, and higher levels of CD122, perhaps also reflecting preferential use of IL-15.

In separate cohorts of infected mice, endogenous tetramer+ T cells were identified at multiple times after infection ([Figure S3A](#SD1){ref-type="supplementary-material"}). As expected, most of these CD8+ tetramer+ T cells were CD127^lo^KLRG1^+^ (short-lived effector cells) at days 9--13 in both tissues. There was an equivalent percentage of CD127^hi^KLRG1^lo^ (memory-phenotype effector cells) in both tissues at this time. Splenic memory T cells transitioned to CD127^hi^KLRG1^lo^ during memory (days 30--45), whereas significantly fewer memory CD8+ T cells in adipose tissue were CD127^hi^KLRG1^lo^ ([Figures S3B](#SD1){ref-type="supplementary-material"} and [S3C](#SD1){ref-type="supplementary-material"}), and most cells were low for both molecules. CX3CR1 has been used to distinguish central memory T (Tcm), effector memory (Tem), and peripheral memory (Tpm) cells that can migrate through peripheral tissues and into circulation ([@R10]). CX3CR1 was highly induced on virus-specific CD8+ T cells in the spleen, though it tended to be expressed on CD127^lo^ cells during memory ([Figures S3B](#SD1){ref-type="supplementary-material"} and [S3C](#SD1){ref-type="supplementary-material"}). Significantly fewer CD8+ T cells in adipose tissue expressed CX3CR1, and tetramer+ CD4+ T cells weakly expressed CX3CR1 in both tissues at all times ([Figures S3D](#SD1){ref-type="supplementary-material"} and [S3E](#SD1){ref-type="supplementary-material"}). There were significantly higher frequencies of adipose tissue CD4+ T cells that expressed Ly6C ([Figures S3D](#SD1){ref-type="supplementary-material"}--[S3F](#SD1){ref-type="supplementary-material"}), an activation marker associated with splenic Th1 cells with limited proliferative recall responses ([@R19]). Overall, endogenous tetramer+ T cells in adipose tissue and spleen show expression patterns that resemble P14 and SMARTA T cells analyzed in those tissues.

Memory P14+ or SMARTA+ T cells were isolated from the adipose tissue and spleen of the same recipient mice, FACS-sorted to high purity, and analyzed by RNA sequencing (RNA-seq) ([Figure 3D](#F3){ref-type="fig"}; [Table S1](#SD2){ref-type="supplementary-material"}). A number of differentially expressed genes were observed when comparing T cells from WAT and spleen ([Figure 3D](#F3){ref-type="fig"}; [Tables S2](#SD3){ref-type="supplementary-material"} and [S3](#SD4){ref-type="supplementary-material"}). For CD8+ T cells, 456 genes were significantly changed (up or down) in expression when comparing WAT cells with splenic cells ([Table S2](#SD3){ref-type="supplementary-material"}). Far more differentially expressed transcripts were observed for CD4+ T cells (2,868 genes) ([Table S3](#SD4){ref-type="supplementary-material"}), possibly reflecting the heterogeneity of CD4+ T cell lineages. Despite these differences in gene expression, when responding to infection, WAT memory T cells accumulated in the spleen and adipose tissue and made cytokines as well as splenic memory T cells ([Figure S2](#SD1){ref-type="supplementary-material"}). Thus, although memory T cells in adipose tissue are clonally related to those in the spleen, WAT memory T cells are physically separate and abundant and show changes in gene and protein expression during homeostasis that suggest they are a unique subset. Moreover, WAT memory T cells are able to vigorously respond to infection.

Diet-Induced Obesity Increases Memory T Cell Number {#S6}
---------------------------------------------------

Obesity is associated with altered immune defenses against infections. To understand the relationship between T cells, viral infection, and obesity, we infected lean or high-fat diet-induced obese mice with LCMV-Armstrong and quantified virus control and antiviral T cell responses at multiple times, including at day 90, when the mice fed a high-fat diet showed a significant increase in body weight and perigonadal adipose weight ([Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}). Both obese and lean mice resolved the infection in the liver, lung, and kidneys within 1 week (data not shown).

Obese and lean mice generated similar numbers of GP~33--41~-specific, NP~396--404~-specific, GP~276--286-~specific, and NP~205--212~-specific CD8+ T cells and GP~61--80~-specific CD4+ T cells at day 9, as measured by tetramer staining and ICCS of spleen cells ([Figure 4C](#F4){ref-type="fig"} and data not shown). Interestingly, obese mice showed less T cell contraction at day 15 and maintained \~ 2- to 3-fold more virus-specific T cells to day 90 in the spleen ([Figures 4C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}).

Obesity significantly increased the number of effector and memory T cells in adipose tissue ([Figures 4C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}, bottom). At day 9, there were \~3-fold more DbGP~33~+CD8+ T cells and 20-fold more IAbGP~67~+CD4+ T cells in the adipose tissue of obese mice compared with lean mice ([Figure 4C](#F4){ref-type="fig"}). The increase was sustained through day 90, when obese mice showed \~8-fold more memory CD8+ T cells and 5-fold more memory CD4+ T cells compared with lean mice. The adipose tissue of obese mice contained more memory T cells that could make IFNg ([Figure 4D](#F4){ref-type="fig"}). The increase in adipose tissue memory T cells in obese mice was largely linked to the increase in adipose tissue mass in these mice ([Figure 4E](#F4){ref-type="fig"}): when normalized, the number of virus-specific CD8+ T cells per gram adipose tissue was similar in mice fed control chow or high-fat chow. The density of virus-specific CD4+ T cells was increased at days 8 and 15 by the high-fat diet, but the obesity-associated increase in memory CD4+ T cells correlated with WAT mass ([Figure 4E](#F4){ref-type="fig"}). Obesity did not change the capacity of memory CD8+ T cells to make IFNg in the spleen or adipose tissue ([Figure 4F](#F4){ref-type="fig"}); however, obesity altered memory CD4+ T cell expression of IFNg, slightly improving IFNg made by spleen cells and slightly decreasing IFNg made by WAT T cells ([Figure 4F](#F4){ref-type="fig"}). In summary, obesity increases memory T cell number in the spleen and in adipose tissue in proportion to adipose tissue mass, without major changes to the ability of T cells to express the antiviral cytokine IFNg.

Immune Obese Mice Succumb to Re-challenge Infection {#S7}
---------------------------------------------------

To understand the effects of obesity on memory cell responses and protection, we vaccinated lean or obese mice using LCMV-Armstrong, allowed the mice to establish a pool of memory cells, then re-challenged the mice with an aggressive variant that widely disseminates (LCMV-Clone13) ([Figure 5A](#F5){ref-type="fig"}). Immune control of LCMV-Clone13 requires a vigorous memory T cell response and antibody, and immune mice typically control re-challenge infection in 5--7 days. Obesity increased T cell memory but did not affect serum levels of virus-specific IgG ([Figure S4A](#SD1){ref-type="supplementary-material"}). Although obesity was associated with impaired regulation of glucose levels ([Figure S4B](#SD1){ref-type="supplementary-material"}), this alteration was similar for both naive and LCMV-immune mice. Upon challenge infection, naive mice and lean immune mice showed modest weight loss and survived the infection ([Figure 5B](#F5){ref-type="fig"} and data not shown). In contrast, immune obese mice showed greater loss of weight, and \~45% rapidly succumbed to infection. We observed that the blood and ascites of the immune obese mice showed greatly elevated lipase activity ([Figure 5C](#F5){ref-type="fig"}), a sign of pancreatitis. We analyzed pancreases from naive and immune mice following the re-challenge infection ([Figure 5D](#F5){ref-type="fig"}).

The pancreases of virus-challenged naive obese mice (second column) showed minimal to no detectable necrosis, and there was no apparent adipocyte necrosis, suggesting that the virus it self does not cause pancreatitis or fat necrosis. Re-challenged immune mice showed both significant influx of leukocytes into the pancreas and acinar cell damage (pale staining versus rich purple stain) compared with naive or unchallenged mice. Following infection, pancreatic damage was far more extensive in the obese mice but restricted to peripheral locations of the pancreas near adipose tissue rather than deeper within the pancreas ([Figure 5D](#F5){ref-type="fig"}, right columns). Von Kossa staining revealed more calcium binding (gray) near the adipose tissue-pancreas boundary ([Figure 5D](#F5){ref-type="fig"}, bottom row). Adipose tissue surrounding the pancreas showed more necrosis in the re-challenged obese immune mice than in the re-challenged lean immune mice or challenged naive mice ([Figure 5D](#F5){ref-type="fig"}, middle row), and there was more calcium deposition onto perigonadal fat (not shown). Trichrome staining also revealed tissue damage at peripheral areas of the pancreas and in adipose tissue of re-challenged obese mice but not lean mice ([Figure S3C](#SD1){ref-type="supplementary-material"}). Re-challenged obese mice showed greatly increased levels of blood IL-6 ([Figure 5E](#F5){ref-type="fig"}), consistent with pancreatitis ([@R28]). TNF was undetectable in blood, but elevated the levels of IFNg suggest strong T cell activity in re-challenged obese mice.

Because virus-specific T cells are numerically increased in WAT and spleen during obesity ([Figures 4C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}), we evaluated whether memory T cells contribute to pathogenesis. Cohorts of LCMV-immune mice were depleted of CD4+ and CD8+ T cells across 2 weeks, which removed T cells systemically, including in adipose tissue (data not shown). T cell depletion prevented lipase release in the obese immune mice following challenge infection ([Figure 6A](#F6){ref-type="fig"}), and there appeared to be less pancreatic necrosis and calcium deposition on adjacent adipose tissue ([Figures 6B](#F6){ref-type="fig"} and [S4C](#SD1){ref-type="supplementary-material"}). Challenged obese mice showed a dramatic reduction in systemic calcium levels compared with challenged lean mice ([Figure 6C](#F6){ref-type="fig"}), but T cell depletion prevented this loss. Re-challenged obese mice showed elevated levels of serum ALT, indicative of hepatocyte damage, which was prevented when T cells were depleted prior to re-infection ([Figure 6D](#F6){ref-type="fig"}). Finally, obese immune mice rapidly developed hypothermia, which was prevented by T cell depletion ([Figure 6E](#F6){ref-type="fig"}). Because all of these features of pathogenesis occurred only in obese LCMV-immune mice and were prevented by T cell depletion, we infer that memory T cell activity in mice with elevated levels of adipose tissue worsens health after re-challenge.

DISCUSSION {#S8}
==========

Obesity is increasingly prevalent throughout the world and is a significant health concern because it is associated with numerous immune-related disorders and susceptibility to infections. Here, we show that obesity predisposes mice to a unique form of pathogenesis during systemic viral infection. We demonstrate that LCMV infects adipose tissue and adipocytes. Virus-specific T cells accumulate in the WAT and are likely responsible for clearing infection there. The T cells in WAT then differentiate into memory T cells that appear phenotypically distinct from memory T cells in circulation or in lymphoid tissues. We also show that obesity increases the number of memory T cells systemically and in adipose tissue. Finally, we show that upon re-challenge, memory T cells respond to infection but cause a unique form of pathogenesis in obese mice that includes significant fat necrosis, systemic loss of calcium, multiple organ injury, and death.

The number of memory T cells in the adipose tissue of lean mice was surprisingly large. For perspective, the magnitude of the T cell response in the fat pads after LCMV is similar or greater than the total number of antigen-specific cells found in the spleens or lymph nodes of mice that have received protective T cell-inducing vaccines (e.g., DNA vaccine, peptide vaccine, recombinant Listeria monocytogenes). Adipose tissue is present throughout the body, so the total reservoir of memory T cells in adipose tissue in mice may be greater than what we have estimated. During obesity, primary T cells in adipose tissue were further increased, resulting in \~10^6^ GP~33~-specific CD8+ T cells at day 8, which is roughly one-third the number of found in the spleen; obesity increased the number GP~61~-specific CD4+T cells in the fat pads to match the number found in the spleen. Obesity also increased the number of memory cells in adipose tissue, resulting in a population that is 10%--20% of the total number of memory T cells found in the spleen. Thus, although the spleen and lymph nodes are conventional places to track T cell responses and memory, our findings show that virus-specific T cells in WAT represent a major population of cells that have been neglected and are sensitive to the physiological changes caused by obesity.

Memory T cells in WAT appear to be unique, showing differences in RNA and protein expression compared with T cells in the spleen ([Figures 3](#F3){ref-type="fig"}, [S1F](#SD1){ref-type="supplementary-material"}, and [S3F](#SD1){ref-type="supplementary-material"}). Recent analyses of memory T cells in WAT have also identified differences in adipose Trm cells versus memory T cells in other peripheral tissues ([@R13]). Likewise, we observe that virus-specific adi-pose T cells are CD44^hi^CD62L^lo^, a profile common to Tem and Trm cells but not Tcm. Roughly half of adipose tissue CD8+ T cells were CD69+ (often associated with Trm cells), as previously reported ([@R13]), though virus-specific CD4+ T cells were uniformly CD69\[C0\]. WAT CD8+ T cells were mostly KLRG1^lo^ but also under-expressed CD127, suggesting that they do not easily fit into the categories of short-lived effector cells or long-lived memory cells as defined for splenic CD8+ T cells, though the absence of KLRG1 is a characteristic of Trm cells in other peripheral tissues. WAT T cells showed relatively low expression of CD103 ([@R13]), an integrin associated with Trm cells in epithelial sites (e.g., lung, skin, intestines), suggesting that T cells in WAT are also distinct from T cells in other non-lymphoid compartments. Memory T cells in adipose tissue showed increased expression of some chemokines (e.g., Cxcr4, Ccr2, Ccr9, Ccr2, Cxcr6) but under-expressed others (S1pr1, S1pr5, Ccr7, Cxcr5, Cx3cr1) compared with splenic memory T cells, suggesting that WAT T cells may be retained by distinct chemokine gradients, such as CXCL12 or CXCL16, which can be induced during viral infection. CX3CR1 expression levels have been used to distinguish Tcm (CX3CR1^lo^), Tem (CX3CR1^hi^), Tpm (CX3CR1^int^), a subset that can recirculates through tissues, lymph, and blood, and Trm (CX3CR1^low/int^), a non-migratory subset that populates peripheral tissues ([@R10]). Most memory CD8+ T cells in adipose were KLRG1^lo^, CD62L^lo^, CX3CR1^lo/-\]^, similar to Trm in other tissues ([@R14]). We could not discern a sizable CX3CR1^int^ subset in WAT, suggesting that few of these cells are Tpm cells, and we have not examined their capacity to recirculate under homeostatic conditions. Adi-pose T cells expressed less CX3CR1 message, though we have not ruled out a role for CX3CL1-mediated endocytosis of CX3CR1 from the cell surface. Interestingly, WAT T cells expressed more Cd36 than splenic T cells, hinting that they may be specialized for fatty acid uptake and metabolism. Finally, early virus-specific memory T cells in adipose tissue show evidence of activation and undergo rapid cell division that is more extensive than the homeostatic cell division observed in lymphoid tissues, an observation consistent with *Yersinia pseudotuberculosis*-specific T cells in adipose tissue ([@R13]). These findings suggest that there are local cytokines (adipokines) or residual antigens in adipose tissue that propagate cell division after infectious virus has been eliminated.

We show that obesity not only increases memory T cell number but converts a protective immune response to a lethal one. It may be that pathogenesis is exaggerated by alterations in glucose metabolism by memory T cells rather than changes to memory T cell abundance or location within adipose tissue. The increase in memory T cell number during obesity may be related to increases in leptin production, which can act on activated T cells that increase their expression of leptin receptor. Leptin signaling improves T cell proliferation and survival in culture ([@R27]; [@R30]), and immune cell functions are reduced when there are deficiencies in leptin-receptor signaling ([@R23]; [@R30]). Obesity reduces the level of anti-inflammatory adiponectin ([@R3]), possibly allowing pro-inflammatory signals to increase T cell frequencies. The outgrowth of memory T cells, including those in adipose tissue, may predispose to T cell-dependent pathogenesis during infection.

Adipose tissue can be targeted by LCMV, pichinde virus, HIV, SIV, adenovirus, vaccinia virus, and several species of parasites or bacteria ([@R4]; [@R6]; [@R37]; [@R41]). T cells in adipose tissue can contribute to the control of acute infections ([Figure 1](#F1){ref-type="fig"}; [@R4]; [@R13]; [@R33]). However, under some circumstances, such as obesity ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}) or heterologous viral infections ([@R4]; [@R33]; [@R40]; [@R41]), T cells mediate pathogenesis. The divergent outcomes likely vary according to the number of memory T cells, as well as tropism and infection dose of the pathogen. Primary infection of mice with VV or LCMV fails to induce pathology in the WAT ([@R41]). However, mice that are hyper-immune to LCMV develop fat necrosis upon challenge with vaccinia viral infection, showing pathogenesis resembling the human syndromes, Weber-Christian disease and erythema nodosum ([@R40]; [@R41]); although no pancreatic abnormalities were noted, roughly \~10% of the vaccinia virus-challenged mice succumbed ([@R41]). Heterologous infections that re-stimulate cross-reactive memory T cells can cause acute fat necrosis ([@R4]; [@R33]), a pathogenic outcome that may be greatly exacerbated in the context of obesity. Thus, extreme pathogenesis occurs when there is an excess of WAT and elevated frequencies of memory T cells.

The lethality seen in re-challenged obese mice was unusually rapid, occurring between days 2 and 4, suggesting that memory T cells acted quickly and did not require major proliferation to cause pathogenesis. We speculate that upon re-challenge, resident memory T cells respond to infected adipocytes or other adipose tissue-associated cells, killing infected cells and making IFNg and TNF. This may cause a massive release of lipid (triglycerides) that is processed to polyunsaturated fatty acids that exacerbate pancreatitis ([@R24]; [@R29]), ultimately leading to greater release of lipases and proteases by adjoining acinar cells ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). The pancreatic lipases may further contribute to adipocyte death, continuing the release of triglycerides and accumulation of polyunsaturated fatty acids that bind calcium ([@R8]). The catastrophic loss of calcium ([Figure 6C](#F6){ref-type="fig"}) may lead to systemic organ failure and death. Thus, we speculate that memory T cells directly kill infected adipocytes, leading to fat necrosis and hypocalcemia; pathogenesis is worse in obese mice, because obese mice have more adipose tissue memory T cells and more lipid in their adipocytes to sequester calcium. Nevertheless, the pancreas can be infected by LCMV, and we have not ruled out a role for virus-specific T cell activity within the pancreas in causing pathogenesis. Our histological evidence shows pancreatic damage along the border with WAT rather than uniformly across the pancreas, suggesting that the pathogenic process is related to WAT. Finally, we do not know whether T cell cytokines or cytolytic activity are essential for pathogenesis.

Pancreatitis is more frequent and severe in obese subjects compared with non-obese individuals ([@R16]; [@R20]). In view of our findings in mice, there should be analyses in humans to assess whether obesity increases the frequency or severity of enteric infections and whether T cells contribute to pancreatitis. Calcium supplementation has been used to treat patients with acute pancreatitis or sepsis ([@R1]), and it may be that replenishing calcium or inhibiting lipases ([@R29]) may avert lethal outcomes during viral infection in obese subjects.

Cumulatively, these data further implicate WAT as an important immunological organ ([@R11]) with an abundant population of T cells that changes during obesity. Future analyses are needed to better understand how obesity-associated changes in adipose tissue-derived cytokines and inflammation alter memory T cell number and function and contribute to increased pathogenesis upon infection.

STAR★METHODS {#S9}
============

CONTACT FOR REAGENT AND RESOURCE SHARING {#S10}
----------------------------------------

Further information and requests for resources and reagents should be directed to the Lead Contact, Jason Whitmire (<jwhitmir@email.unc.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S11}
--------------------------------------

### Mice {#S12}

Male C57BL/6J mice were used in these studies. Male mice were used because they quickly gain weight when fed high fat diet. In some experiments, T cells were isolated from SMARTA TCR-transgenic (Tg+) mice or from P14 TCR Tg+ mice. The TCR Tg+ mice were crossed to B6.PL-*Thy1*^*a*^/CyJ mice to generate TCR-Tg+/Thy1.1+ mice or to B6.SJLPtprc aPep3b/BoyJ to generate TCR-Tg+/ Ly5a+ mice. Adult male mice (8--10 weeks old) were infected by intraperitoneal injecton of 2×10^5^ plaque-forming units (PFU) LCMV-Armstrong strain. Other mice, including age-matched naive or LCMV-immune mice, were challenged with LCMV-Clone13 (2×10^6^ PFU, ip) at roughly 21--23 weeks of age and observed for up to 5 days for physical signs of illness. Animals were euthanized upon development of severe disease (eg, body temperature \< 30^∘^C). All mouse experiments were approved by the University of North Carolina Hill Institutional Animal Care and Use Committee.

### Virus {#S13}

Plaque-purified LCMV was used to infect BHK-21 monolayers to prepare virus stocks. Virus stocks were mycoplasma free. Quantitation of infectious virus in the tissues was done by plaque assay on Vero cell monolayers.

### Diet-induced obesity {#S14}

Mice were fed high fat diet (60% of calories from fat) or control diet (10% of calories from fat) starting at 4--5 weeks of age. Mice were fed the same diet until they were sacrificed during experiments. Obese mice were \> 40 g body weight and 12--15 weeks old when initially infected with LCMV-Armstrong.

### T cell depletion {#S15}

Mice were depleted of CD4+ and CD8+ T cells by 6 i.p. injections of 100 μg of anti-CD4 and anti-CD8 (or isotype controls) across 2 weeks ([@R25]).

### Leukocyte isolation and purification {#S16}

Single-cell suspensions were prepared from spleens, lymph nodes, blood, or perigonadal fat pads. Spleens and lymph nodes were physically disrupted over a 70 mm nylon cell strainer (Corning, NY). Erythrocytes were removed from spleen and bone marrow suspensions using ACK lysing buffer (Life Technologies-BRL, NY). Blood was spun over a histopaq cushion; leukocytes were isolated from the interphase. Fat pads were cut into small pieces, digested at 37^∘^C for 30 min with 1mg/ml collagenase (Calbiochem) and 10mg/ml DNase I (Sigma-Aldrich) in 10% RPMI before filtering through a 70 μm cell strainer. Leukocytes released from the fat pad were suspended in 44% Percoll, underlayed with 56% Percoll, and isolated from the interphase after centrifugation.

### Adipocyte purification {#S17}

Adipocytes were separated using a collagenase and differential centrifugation method ([@R7]; [@R12]). Perigonadal WAT (100mg from 3 mice) was minced, exposed to 1mg/ml collagenase, gently filtered through a 250 μm nylon mesh, and centrifuged for 10 minutes at 300 g. Three layers emerged with a low-density adipocyte layer on top, an aqueous layer of media, and a cell pellet. These 3 layers were collected separately, washed in media, and added to Vero cell monolayers in a plaque assay.

### Cell culture {#S18}

Vero cells and BHK cells were propagated in DMEM supplemented with 5% heat inactivated FBS, penicillin, streptomycin, and fungizone.

METHOD DETAILS {#S19}
--------------

### Flow cytometry {#S20}

Single-cell leukocyte suspensions were prepared from the spleens and perigonadal WAT of male mice. Erythrocytes were removed from splenocyte preparations using ACK lysing buffer. The cells were washed and re-suspended in either 1% or 10% RPMI. The cells were stained directly *ex vivo* with combinations of fluorescently labeled mAbs or fluorescent-tetramers in the presence of unlabeled Abs against FcRs to block fluorochrome-conjugated Abs from binding to FcR+ cells. The intracellular cytokine staining (ICCS) assay was performed by culturing splenocytes with or without LCMV peptide in the presence of brefeldin A. After 5 hours of incubation, cells were stained for surface markers, washed, fixed with formaldehyde, and then permeabilized and exposed to mAbs specific for IFN- γ ,IL-2, and TNF. Antibody-stained cells were detected by FACSCalibur or LSRII cytometers (BD Biosciences), and the data were analyzed with FlowJo software (Tree Star).

### Intravascular staining {#S21}

This method distinguishes T cells that are located in the parenchyma of tissues from those in capillaries ([@R2]). Mice were intravenously injected with PE-conjugated anti-CD4 or anti-CD80α to label T cells in circulation. Three minutes later, tissues were harvested and single cell suspensions were re-stained with FITC-conjugated anti-CD4 or anti-CD8 to identify to T cells within the tissue.

### Cell proliferation assays {#S22}

Intracellular staining for Ki67 was performed using a kit from BD Biosciences with anti-nuclear antigen (clone Ki-67). For the BrdU incorporation analyses, mice were given an initial intraperitoneal injection of 1 mg BrdU and fed 0.8 mg/ml BrdU in drinking water for 7 days. Incorporated BrdU in T cells was detected using an anti-BrdU flow kit from BD Biosciences, followed by flow cytometry analysis.

### Antibody ELISA {#S23}

Dilutions of sera from uninfected or virus-infected mice were assayed by ELISA using 96-well plates coated with virus-infected BHK cell lysate or uninfected BHK cell lysate. IgG bound to the plates was detected using HRP-conjugated anti-IgG.

### RNA-sequencing {#S24}

Virus-specific TCR-transgenic T cells were given to 10--20 mice followed by infection to generate memory cells. At day 50 post-infection, memory cells in the spleen or adipose tissue were identified by surface stained and FACS-sorted to \~98% purity by a FACSAria-II machine at the UNC FACS core. RNA was extracted from Ȉ10^5^ sorted cells (pooled from 5--10 mice each in 2 independent replicates; [Table S1](#SD2){ref-type="supplementary-material"}), and purified on oligo(dT) dynabeads for cDNA amplification. Adaptors were ligated and 100 bp reads were sequenced by the HiSeq 2000 Analyzer at the Scripps Microarray & NGS Core Sequencing Facility, La Jolla CA. The Genome Analyzer Pipeline Software (Casava v1.9) was used to perform the early data analysis, including base calling and demultiplexing of the barcodes. The reads in the fastq files were trimmed with the TruSeq adaptor and an additional 3bp on each end. The reads were then aligned to the mouse (mm9) genome using open source TopHat 2.0.9 and Bowtie2 programs. Reads were mapped to individual genes using HTSeq-count. EdgeR was used to identify significant differences between datasets (FDR \< 0.05) and generate logCPM values that were used to generate scatterplots. Data were deposited in GEO under accession number GSE110212.

### Histology & Immunofluorescence {#S25}

Whole perigonadal adipose tissue samples were isolated in PBS, fixed in 10% buffered formalin overnight, and then stored in 100 proof EtOH. For some samples, 6 mm sections were cut and put onto slides and stained with hematoxylin and eosin (H&E) or Von Kossa stains. These samples were visualized through light microscopy with phase contrast on an Olympus BX61 microscope at the UNC Microscopy Services Laboratory. In other experiments, the perigonadal adipose tissue of male mice was whole-mount stained to visualize adipocyte lipid droplets (BODIPY~C12~), nuclei (Hoechst), and CD3+ cells (clone-17A2) ([@R18]; [@R25]), followed by imaging analysis on a Zeiss-710 confocal laser-scanning microscope at the UNC Microscopy Services Laboratory. All histological processes were conducted by the Animal Histopathology Core Lab, Lineberger Comprehensive Cancer Center.

### Lipase measurements {#S26}

Lipase activity in peritoneal cavity and serum was determined Lipase Activity Colorimetric Assay Kit II (BioVision, Milpitas, CA). Peritoneal fluid was collected by introducing 2ml of sterile saline into the peritoneal cavity and then recovering the sample. The peritoneal fluid was clarified by centrifugation (5000 x g, 20 min) before the lipase assay.

### Calcium measurements {#S27}

Serum calcium concentrations were quantified by clinical chemistry tests at the UNC Animal Histopathology Core.

### Alanine aminotransferase measurements {#S28}

MaxDiscovery ALT Color Endpoint Assay was used to measure ALT activity in serum.

### Glucose tolerance test {#S29}

Mice were fasted for 16 hours and then injected with 1g/kg D-glucose ip. Blood was sampled from the tail vein at 15, 30, 60, and 120 minutes and with glucose concentrations determined by Bayer Contour Next glucometer.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S30}
---------------------------------------

Results are expressed as means ± SEM. Statistical analyses and graphing were done using Prism 6 software. Comparisons between groups were performed using unpaired two-tailed Student's t test or one-way analysis of variance (ANOVA) with Bonferroni multiple comparison test. Differences were considered significant when p \< 0.05 (\*); \< 0.01 (\*\*); \< 0.001 (\*\*\*). EdgeR was used to identify significant differences between datasets (FDR \< 0.05) and generate logCPM values that were used to draw the scatterplots.

DATA AND SOFTWARE AVAILABILITY {#S31}
------------------------------

The accession numbers for the RNA-seq data for the P14 and SMARTA T cells isolated from spleen or WAT are deposited in the GEO database under record number GSE110212.
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![LCMV Infection of White Adipose Tissue\
B6 mice were given LCMV-Armstrong (2 3 10^5^ PFUs, intraperitoneal \[i.p.\]), and levels of virus in adipose and spleen and leukocyte abundance in adipose were determined.\
(A) The line graphs represent virus levels mean (±SEM) in the spleen or perigonadal white adipose tissue (WAT) at the indicated days after infection. The dotted horizontal line indicates the limit of detection. Data are pooled from two experiments with three to six mice per group.\
(B) Perigonadal fat pads were isolated from LCMV-infected mice at day 5 and assessed for viral infection. Gentle centrifugation was used to separate low density mature adipocytes from denser stromal vascular fraction (SVF) cell populations. The graph shows quantification of infectious virus (n = 3, one experiment), with an example of plaques developing in Vero cells.\
(C) Perigonadal adipose tissue was harvested at the indicated days of infection and analyzed by microscopy. Top: representative sections stained with H&E; scale bar, 120 mm. Bottom: whole-mount staining reveals the lipid droplet in adipocytes (BODIPY~C12~; red), cell nuclei (Hoechst; blue), and infiltrating T cells (anti-CD3; green); scale bar, 100 mm. Data are representative of two experiments with two or three mice per group.\
(D) Total number of leukocytes, CD8+ T cells, and CD4+ T cells recovered from fat pads before infection (n = 8) and at day 8 post-infection (n = 6). Data were analyzed using unpaired Student's t test with \*\*p \< 0.01 and \*\*\*\*p \< 0.0001.](nihms-1534186-f0002){#F1}

![Virus-Specific T Cells Accumulate in WAT\
Virus-specific T cells in adipose tissue and spleen were quantified at multiple times after acute infection by tetramer staining and ICCS.\
(A) Representative dot plots identify DbGP~33~+CD8+ T cells (left) and IAbGP~67~+CD4+ T cells (right) before infection and at days 8 and 70 post infection. The numbers indicate the frequency of the tetramer+ cells among all live cells in the spleen or among leukocytes isolated from the fat pads.\
(B) The number (mean ± SEM) of tetramer-positive T cells per spleen or fat pads at the indicated times post-infection. Data are drawn from two independent experiments with three to five mice per group.\
(C) Representative dot plots show GP~33~-specific CD8+ T cells or GP~61~-specific CD4+ T cells expression of IFNg after peptide stimulation. The analyses are from the indicated days after infection, with numbers indicating the percentage of IFNg+ cells among all cells.\
(D) The number (mean ± SEM) of IFNg+ epitopespecific T cells per tissue in spleen and fat pads as measured using ICCS assay at the indicated times post-infection. Data represent two experiments with five to nine mice per group.\
(E) T cell co-expression of IFNg with TNF or IFNg with IL-2 in the spleen or fat pads at day 8. CD8+ T cells were stimulated with GP33--41 peptide;CD4+ T cells were stimulated with GP61--80 peptide.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1534186-f0003){#F2}

![A Distinct Subset of Memory T Cells in WAT\
(A and B) B6 recipient mice (Ly5a--) were given TCR-transgenic (Tg+) 2 × 10^4^ P14 CD8+ (Ly5a+) T cells or SMARTA CD4+ (Ly5a+) T cells and then infected with LCMV-Armstrong 1--2 days later. At day 38 post-infection, intravascular (i.v.) staining was performed to label circulating donor CD4+ or CD8+ T cells and distinguish them from T cells within the spleen or adipose tissue.\
(A) An illustration of the method whereby intravenous staining is coupled to *ex vivo* staining that labels all T cells in suspension.\
(B) Representative dot plots showing the proportion of T cells protected from intravenous staining because of their location within the parenchyma of the spleen or WAT. Note that the vast majority of T cells purified from WAT are not contaminants from circulating subsets. Data represent three independent experiments with three or four mice per group. (C and D) B6 recipient mice (Ly5a--) were given TCR-transgenic (Tg+) splenic 2 × 10^4^ P14 (Ly5a) or SMARTA (Ly5a+) T cells and then infected with LCMV-Arm 1--2 days after engraftment. At day 38, spleen and WAT cells were isolated and co-stained to identify the donor T cells and their expression of phenotypic markers.\
(C) The histograms are gated on P14 memory cells (top) or SMARTA memory cells (bottom) and show their surface expression of the indicated molecules. Memory donor cells from spleen (red) or WAT (blue) are shown with naive splenic Tg+ cells (black). Data represent two experiments with four to six mice per group.\
(D) Memory P14 and SMARTA donor cells from day 50 post-infection were FACS-purified from the spleen or adipose tissue and subjected to RNA sequencing to identify changes in gene expression. The dot plots show donor cells from adipose tissue before and after FACS. The graphs show EdgeR analysis of the RNA-seq data with log fold change (logFC) in RNA expression in WAT T cells relative to splenic T cells plotted against theamount of RNA per cell, expressed as log counts per million reads (logCPM). The red circles identify significant (false discovery rate \[FDR\] \< 0.05) differences. These data are from two replicated experiments. Each replicate used pooled RNA isolated from ten (P14) or five (SMARTA) recipient mice.\
See also [Figures S2](#SD1){ref-type="supplementary-material"} and [S3](#SD1){ref-type="supplementary-material"} and [Tables S1](#SD2){ref-type="supplementary-material"}, [S2](#SD3){ref-type="supplementary-material"}, and [S3](#SD4){ref-type="supplementary-material"}.](nihms-1534186-f0004){#F3}

![Diet-Induced Obesity Increases Memory T Cell Number\
Mice were fed lean or high-fat diet for 8--9 weeks to establish obesity prior to LCMV-Armstrong infection. The number of virus-specific T cells in the spleen and fat pads was determined by tetramer staining and ICCS at multiple times after infection.\
(A) An illustration of the experimental approach.\
(B) The body weight of the mice and perigonadal fat pads at day 90 post-infection.\
(C) The line graphs show the number (mean ± SEM) of tetramer-positive T cells per spleen (top) or WAT (bottom) at the indicated times post infection. Data are pooled from two to four independent experiments with a total of three to nine mice per group.\
(D) The scatterplots show the number of GP~33-~specific or GP~61~-specific memory T cells that can make IFNg at day 90, as determined by ICCS assay. Each circle represents an individual mouse. Data represent four experiments with nine mice per group.\
(E) The line graphs represent the number (mean ± SEM) of DbGP~33~+CD8+ (left) or IAbGP~67~+CD4+ (right) T cells per WAT divided by the weight of the fat pad. Data represent two or four experiments with three to nine mice per group.\
(F) Lymphocytes were isolated from the spleen and fat pads of lean or obese mice at day 90 post infection and exposed to the indicated peptide in an ICCS assay. The graphs show the geometric mean fluorescence intensity (+SEM) among IFNg expression by T cells. Data represent four experiments with nine mice per group.\
Significance determined by unpaired Student's t test: \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.001.](nihms-1534186-f0005){#F4}

![Immune Obese Mice Develop T Cell-Dependent Lethal Acute Pancreatitis upon Re-challenge\
Cohorts of mice were fed lean or high-fat diet starting at 4--5 weeks of age until 13--15 weeks of age. Lean mice were \<29 g (n = 10), and obese mice were \>40 g (n = 13). Some of the mice were immunized with LCMV-Armstrong, and the rest were left LCMV naive. Sixty-five days later, the mice were challenged with LCMV-Clone13 (2 × 10^6^ PFUs, i.p.) and analyzed 2 or 5 days later.\
(A) An illustration of the experimental approach.\
(B) Survival of naive (solid lines) and immune (dashed lines) mice after challenge, including mice requiring humane euthanasia. Among the re-challenged LCMV-immune mice, a Mantel-Cox log rank test revealed a significant difference (p = 0.0039) between the naive and obese mice. Data represent 7--16 mice/group.\
(C) Lipase activity in ascites (left) and serum (right) at 2 days post-challenge infection. Dots on figure represent individual mice (3--6 per group, two independent experiments).\
(D) Representative pancreas sections from the indicated four groups of mice at 2 days post-challenge infection. Sections were stained with H&E (upper two rows) or Von Kossa stain to reveal calcium deposition (dark gray, bottom row). The upper images show regions within the pancreas; the middle bottom images show the margin of the pancreas. Scale bar, 150 μm.\
(E) Concentrations of IL-6, IFNg, and TNF in blood. Symbols represent individual mice (3 or 4 per group, two independent experiments). Significance determined by unpaired Student's t test: \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.001.](nihms-1534186-f0006){#F5}

![Memory T Cells Mediate Acute Pancreatitis and Adipose Tissue Necrosis\
Cohorts of lean or obese immune mice were treated with antibodies to CD8 and CD4 to deplete T cells or treated with isotype control antibodies before challenge. Mice were analyzed 2 days after infection. Data compiled from two independent experiments with four to six mice per group.\
(A) Lipase activity in the peritoneal cavity.\
(B) Sections of pancreas and adipose stained with Von Kossa. Scale bar, 150 μm.\
(C) Calcium concentrations in blood.\
(D) ALT concentration in blood.\
(E) Body temperature in individual mice. Significance determined by unpaired Student's t test: \*p \< 0.05, \*\*p \< 0.01, and \*\*\*p \< 0.001.\
(E) shows significance by paired Student's t test. See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1534186-f0007){#F6}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                             SOURCE                                                               IDENTIFIER
  ----------------------------------------------- -------------------------------------------------------------------- ---------------------------------------------------------------------
  Antibodies                                                                                                           
  TruStain fcX (anti-mouse CD16/32)               Biolegend                                                            Cat\#101320; RRID: AB_1574975
  Anti-mouse CD3, BV421, clone 1452C11            Biolegend                                                            Cat\#100335; RRID: AB_10898314
  Anti-mouse CD4, APC, clone RM45                 Biolegend                                                            Cat\#100516; RRID: AB_312719
  Anti-mouse CD4, PE, clone RM45                  Biolegend                                                            Cat\#100511; RRID: AB_312714
  Anti-mouse CD8α, APC, clone 536.7               Biolegend                                                            Cat\#100712; RRID: AB_312751
  Anti-mouse CD80α, PE, clone 536.7               Biolegend                                                            Cat\#100707; RRID: AB_312746
  Anti-mouse CD8β, FITC, clone YTS156.7.7         Biolegend                                                            Cat\#126605; RRID: AB_961293
  Anti-mouse CD11a, FITC, clone M17/4             Biolegend                                                            Cat\#101106; RRID: AB_312779
  Anti-mouse CD36, APC, clone HM36                Biolegend                                                            Cat\#102611; RRID: AB_571994
  Anti-mouse CD44, FITC, clone IM7                Biolegend                                                            Cat\#103006; RRID: AB_312957
  Anti-mouse CD44, Pacific Blue, clone IM7        Biolegend                                                            Cat\#103019; RRID: AB_493682
  Anti-mouse CD62L, PE, clone MEL-14              Biolegend                                                            Cat\#104407; RRID: AB_313094
  Anti-mouse CD69, PE, clone H1.2F3               Biolegend                                                            Cat\#104507; RRID: AB_313110
  Anti-mouse CD69, BV605, clone H1.2F3            Biolegend                                                            Cat\#104529; RRID: AB_11203710
  Anti-mouse CD103, AF488, clone 2E7              Biolegend                                                            Cat\#121407; RRID: AB_535949
  Anti-mouse CD103, APC-Cy7, clone 2E7            Biolegend                                                            Cat\#121431; RRID: AB_2566551
  Anti-mouse CD122, PE, clone 5H4                 Biolegend                                                            Cat\#105905; RRID: AB_2125737
  Anti-mouse CD127, APC, clone A7R34              Biolegend                                                            Cat\#135011; RRID: AB_1937217
  Anti-mouse CD127, APC-Cy7, clone A7R34          Biolegend                                                            Cat\#135039; RRID: AB_2566160
  Anti-mouse CCR7, PE, clone 4B12                 Biolegend                                                            Cat\#120105; RRID: AB_389357
  Anti-mouse CCR9, FITC, clone 9B1                Biolegend                                                            Cat\#129705; RRID: AB_1227482
  Anti-mouse CXCR4, AF647, clone L276F12          Biolegend                                                            Cat\#146503; RRID: AB_2562590
  Anti-mouse CXCR6, PE, clone SA051D1             Biolegend                                                            Cat\#151103; RRID: AB_2566545
  Anti-mouse CX3CR1, PE, clone SA011F11           Biolegend                                                            Cat\#149005; RRID: AB_2564314
  Anti-mouse KLRG1, PE, clone 2F1/KLRG1           Biolegend                                                            Cat\#138407; RRID: AB_10574005
  Anti-mouse KLRG1, BV605, 2F1/KLRG1              Biolegend                                                            Cat\#138419; RRID: AB_2563357
  Anti-mouse PD1, PE, clone 29F.1A12              Biolegend                                                            Cat\#135205; RRID: AB_1877232
  Anti-mouse Ly5a, APC, clone A20                 Biolegend                                                            Cat\#110713; RRID: AB_313502
  Anti-mouse Ly6c, FITC, clone HK1.4              Biolegend                                                            Cat\#128005; RRID: AB_1186134
  Anti-mouse Ly6c, BV605, clone HK1.4             Biolegend                                                            Cat\#128035; RRID: AB_2562352
  Anti-mouse Thy1.1, OX-7, clone HIS51            Biolegend                                                            Cat\#202515; RRID: AB_961438
  Anti-mouse Ki67, FITC, clone Ki-67              BD Biosciences                                                       Cat\#556026; RRID: AB_396302
  Anti-BrdU, FITC, clone B44                      BD Biosciences                                                       Cat\#347583; RRID: AB_400327
  Anti-mouse IFN-γ, FITC, clone XMG1.2            Biolegend                                                            Cat\#505806; RRID: AB_315400
  Anti-mouse TNF, APC, clone MP6-XT22             Biolegend                                                            Cat\#506308; RRID: AB_315429
  Anti-mouse IL-2, APC, clone JES65H4             Biolegend                                                            Cat\#503810; RRID: AB_315304
  Anti-mouse IgG-HRP                              AbCam                                                                Cat\#Ab97023; RRID: AB_10679675
  InVivoMAb anti-mouse CD8α, clone 2.43           BioXcell                                                             Cat\#BE0061; RRID: AB_1125541
  InVivoMAb anti-mouse CD4, cloneGK1.5            BioXcell                                                             Cat\#BE00031; RRID: AB_1107636
  InVivoMAb rat IgG2b isotype control             BioXcell                                                             Cat\#BE0090; RRID: AB_1107780
  Bacterial and Virus Strains                                                                                          
  LCMV-Armstrong                                  Whitmire laboratory                                                  N/A, generated in house
  LCMV (Clone 13)                                 Whitmire laboratory                                                  N/A, generated in house
  Chemicals, Peptides, and Recombinant Proteins                                                                        
  High-fat chow                                   Research Diets                                                       D12492
  Control chow                                    Research Diets                                                       D12450B
  Brefeldin A Solution (1,000X)                   Biolegend                                                            Cat\#420601
  Fixation Buffer                                 Biolegend                                                            Cat\#420801
  Intracellular Permeabilization Buffer           Biolegend                                                            Cat\#421002
  Biotinylated DbGP3341 monomer                   NIH Tetramer core                                                    N/A
  Biotinylated DbNP396404 monomer                 NIH Tetramer core                                                    N/A
  Biotinylated DbGP276286 monomer                 NIH Tetramer core                                                    N/A
  APC-conjugated I-AbGP67 tetramer                NIH Tetramer core                                                    N/A
  Streptavidin-Allophycocyanin                    Biolegend                                                            Cat\#405207
  Heparin                                         Sanofi-Aventis                                                       Lovenox
  RPMI                                            Lonza                                                                Cat\#12167F
  FBS                                             GIBCO                                                                Cat\#26140079
  ACK lysing buffer                               Life Technologies-BRL                                                Cat\#A1049201
  Collagenase, Type IV                            Calbiochem                                                           Cat\#17104019
  Percoll                                         GE Healthcare                                                        Cat\#17089102
  DNase I                                         Sigma-Aldrich                                                        Cat\#D4527
  ExoSAP-IT                                       Affymetrix                                                           Cat\#78200
  BODIPY~C12~                                     Invitrogen                                                           D3835
  Hoechst                                         Invitrogen                                                           H1399
  Critical Commercial Assays                                                                                           
  RNeasy Mini Kit                                 QIAGEN                                                               Cat\#74106
  MaxDiscovery ALT Color Endpoint Assay           Bioo Scientific                                                      Cat\#346008
  Lipase activity colorimetric assay kit II       BioVision                                                            Cat\#K722
  Ghost Dye UV 450                                Tonbobio                                                             Cat\#130868
  ULtraComp eBeads                                ThermoFisher Scientifc                                               Cat\#01-2222-41
  IL-6 ELISA MAX Standard Set                     BioLegend                                                            Cat\#431301
  IFN-γ ELISA MAX Standard Set                    Biolegend                                                            Cat\#430801
  TNF-alpha DuoSet ELISA                          R&D SYSTEMS                                                          DY41005
  Deposited Data                                                                                                       
  RNA seq: CD8~+~ T cells; adipose                This paper                                                           GEO Accession :GSE110212
  RNA seq: CD8+ T cells; spleen                   This paper                                                           GEO Accession :GSE110212
  RNA seq: CD4+ T cells; adipose                  This paper                                                           GEO Accession :GSE110212
  RNA seq: CD4+ T cells; spleen                   This paper                                                           GEO Accession :GSE110212
  Experimental Models: Cell Lines                                                                                      
  Vero-E6                                         Michael Buchmeier                                                    The Scripps Research Institute, La Jolla, CA
  BHK-21                                          American Type Culture Collection                                     Cat\#CCL-10
  Experimental Models: Organisms/Strains                                                                               
  Mouse: C57BL/6J                                 Jackson Laboratory (purchased during last 7 years and bred at UNC)   Cat\#000664
  Mouse: B6.PL-*Thy1*^*a*^/CyJ                    Jackson Laboratory (purchased during last 7 years and bred at UNC)   Cat\#000406
  Mouse: B6.SJL-*Pfprc*^*a*^*Pepc*^*b*^/BoyJ      Jackson Laboratory (purchased during last 7 years and bred at UNC)   Cat\#002014
  Mouse: P14+ TCR-Tg (B6.Ly5a)                    Backcrossed in Whitmire lab                                          N/A
  Mouse: SMARTA+ TCR-Tg (B6.Ly5a)                 Backcrossed in Whitmire lab                                          N/A
  Software and Algorithms                                                                                              
  Flo-Jo Software (version 9.8.3)                 Tree Star                                                            [https://www.flowjo.com](https://www.flowjo.com/)
  Prism 7                                         GraphPad                                                             [https://www.graphpad.com](https://www.graphpad.com/)
  Genome Analyzer Pipeline Software               Casava v1.9                                                          [https://www.illumina.com](https://www.illumina.com/)
  TopHat 2.0.9                                    Johns Hopkins University                                             <https://ccb.jhu.edu/software/tophat/index.shtml>
  Bowtie2                                         Johns Hopkins University                                             <http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>
  EdgeR                                           Walter and Eliza Hall Institute                                      <http://www.bioconductor.org/packages/release/bioc/html/edgeR.html>

###### Highlights

-   A large and unique subset of memory T cells is present in white adipose tissue

-   Obesity greatly increases memory T cell frequencies in lymphoid and adipose tissue

-   Obesity leads to an unusual form of T cell-mediated pathogenesis during infection
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